Loxapine Tablets

Form: Oral Capsules

Strength: 5 mg, 10 mg, 25 mg, 50 mg

Reference Brands: Loxitane®(US)

Category: Antipsychotropic Drugs

Loxapine tablets are FDA-approved in the United States for the treatment of schizophrenia and are used off-label for other psychotic disorders. In the EU, Loxapine is approved in select countries under national procedures, primarily for managing chronic schizophrenia. Regulatory requirements include compliance with GMP standards, bioequivalence studies, psychiatric safety data, and labeling that highlights sedation and extrapyramidal risk. EU registration may require bridging data if centrally approved alternatives exist. For global buyers seeking dossier-ready Loxapine tablets and other forms such as inhalation powder, visit Pharmatradz.com — your trusted B2B platform for pharmaceutical sourcing.